New diabetes clinical trial: SGLT2i Effect on PTDM Development and Kidney Allograft Function in Non-diabetic Kidney Transplant Recipients: A Randomized, Doubleblind, Placebo Controlled, National Multicenter Trial
Published on: 2026-07-02T04:00:00Z
Conditions: Kidney Transplant Recipient; Sodium Glucose Co-Transporter 2 Inhibitors; Non-Diabetic Patients; Randomized Controlled Trial (RCT); Placebo Control Design; Post Transplant Diabetes Mellitus
Interventions: Drug: SGLT2i; Drug: Placebo
Sponsors: Odense University Hospital; Aarhus University Hospital; Copenhagen University Hospital, Denmark
Not yet recruiting
https://ift.tt/6I1A4Zt
Conditions: Kidney Transplant Recipient; Sodium Glucose Co-Transporter 2 Inhibitors; Non-Diabetic Patients; Randomized Controlled Trial (RCT); Placebo Control Design; Post Transplant Diabetes Mellitus
Interventions: Drug: SGLT2i; Drug: Placebo
Sponsors: Odense University Hospital; Aarhus University Hospital; Copenhagen University Hospital, Denmark
Not yet recruiting
https://ift.tt/6I1A4Zt
Comments
Post a Comment